| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
689 |
633 |
$75K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
377 |
369 |
$42K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
248 |
228 |
$24K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
166 |
161 |
$17K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
97 |
91 |
$7K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
97 |
91 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
263 |
123 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
562 |
495 |
$742.72 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
233 |
221 |
$418.66 |
| 87428 |
|
20 |
12 |
$0.00 |